Amprius Technologies won a $75 million grant from the Department of War to convert an existing EV battery line into a domestic production facility for unmanned aerial system cells. The retrofitted line will produce 12 million high-energy density cells annually by early 2028, meeting National Defense Authorization Act domestic sourcing mandates.
What's happening
- Amprius received $75 million from the DoW's Industrial Base Analysis and Sustainment program to retrofit a South Korean-operated U.S. production line for high-energy density drone batteries.
- The retrofit targets 12 million annual cell capacity by early 2028, converting existing EV battery manufacturing infrastructure to NDAA-compliant pouch cells.
- The total project cost is approximately $100 million, including in-kind investments from Amprius and its South Korean manufacturing partner.
Why it matters
- U.S. autonomy programs face battery supply constraints; this line addresses 12 million annual cell demand for Group 1-3 drones under NDAA domestic sourcing rules.
- The grant secures a domestic production base for advanced battery technology, reducing reliance on foreign suppliers for critical unmanned systems components.
- Amprius expands its manufacturing network across China, South Korea, and now reinforced domestic U.S. capacity, enabling scaled delivery to defense customers.
Going deeper
- The retrofit repurposes an existing EV production line rather than building new capacity, accelerating deployment and lowering total project capital requirements.
- NDAA compliance requires U.S. manufacturing; Amprius' South Korean partner's domestic U.S. facility satisfies this requirement while leveraging established manufacturing relationships.
Financial impact
- Amprius receives $75 million in non-dilutive government capital in 2026, boosting cash available for operational deployment and manufacturing expansion.
- Revenue recognition will begin when the retrofitted line achieves commercial production and ships NDAA-compliant cells, expected in early 2028 and thereafter based on contract volumes.
- The grant funds capex for line conversion; timing of cash draw and accounting treatment depend on the IBAS program's disbursement schedule and construction milestone triggers, timing not disclosed.
The intrigue
- Amprius partners with an unnamed South Korean manufacturer operating U.S. facilities; the identity and scope of that partnership, including equity or financial arrangements, remain undisclosed.
- The company's reference to 'existing contract manufacturing relationships' implies pre-existing demand, but order volumes and customer names are not identified.
The fine print
- The $75 million grant is explicitly described as 'up to' that amount, signaling a potential ceiling with actual disbursement tied to milestones or performance metrics.
- Project completion is planned for early 2028; delays in retrofit or line validation could defer revenue recognition and customer supply.
- NDAA compliance is a stated objective but no independent certification process or timeline for validation is mentioned.